Sales & Earnings In Brief: Prestige Brands, Merck, Herbalife, Reckitt
This article was originally published in The Tan Sheet
Executive Summary
Prestige feels effects of J&J relaunches; Merck CEO urges long view on Consumer Care; Herbalife still growing in North America; Reckitt boosts brand equity investments; sales of Bayer’s OTCs “gratifying;” Church & Dwight gummies best expectations; more Sales & Earnings In Brief.
You may also be interested in...
Herbalife Pushes To Counter Pyramid Scheme Narrative
The multilevel marketer of weight-management shakes and other nutritionals says its independent distributor network, far from being a pyramid scheme, in fact is essential in helping people lose weight and adopt healthy lifestyles, according to Herbalife executives.
Reckitt Deals Feed OTC Domination Plan
Reckitt Benckiser CEO Rakesh Kapoor plays up the firm’s potential to dominate the fragmented global consumer health product market and says Reckitt is better positioned than big pharma firms to manage OTC businesses. Reckitt continued its emerging markets focus with OTC deals in Latin America and China.
In Brief
Asthma inhaler bill vote delayed; fatal plant explosion rocks krill oil producer Neptune; ProPhase grows despite weak cold/flu trend; FTC general counsel leaves; Nu Skin acquires NOX Technologies; more news in brief.